世界の女性用健康診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Womens Health Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5383 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、女性用健康診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（出生前診断、ダウン症、HPV、出生前診断、妊娠検査薬、その他）、用途別市場規模（病院、在宅医療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・女性用健康診断の市場動向 ・企業の競争状況、市場シェア ・女性用健康診断の種類別市場規模と予測2016-2027（出生前診断、ダウン症、HPV、出生前診断、妊娠検査薬、その他） ・女性用健康診断の用途別市場規模と予測2016-2027（病院、在宅医療） ・女性用健康診断の北米市場規模2016-2027（アメリカ、カナダ） ・女性用健康診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性用健康診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性用健康診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性用健康診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Agilent Technologies, Inc.、Ariosa Diagnostics, Inc、Bio-Rad Laboratories, Inc、Illumina, Inc、Laboratory Corporation of America Holdings、Natera, Inc、PerkinElmer, Inc、Sequenom, Inc、LifeCodexx、Cenata、Berrygenomics、BGI） ・結論

Women are more prone to certain diseases, mostly related to menstrual disorders, depression, osteoporosis, obesity, and autoimmune diseases. Women’s major health issues are related to the reproductive system that includes infertility, polycystic ovarian syndrome, menopause, and cancers such as breast cancer, cervical cancer, and urological disorders. This report analzyed the womens health diagnostics product.

Market Analysis and Insights: Global Womens Health Diagnostics Market
The global Womens Health Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Womens Health Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Womens Health Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Womens Health Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Womens Health Diagnostics market.

Global Womens Health Diagnostics Scope and Market Size
Womens Health Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Womens Health Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prenatal Testing
Down Syndrome
HPV
Fertility Test
Pregnancy Test
Other

Segment by Application
Hospitals
Home Care

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Agilent Technologies, Inc.
Ariosa Diagnostics, Inc
Bio-Rad Laboratories, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Natera, Inc
PerkinElmer, Inc
Sequenom, Inc
LifeCodexx
Cenata
Berrygenomics
BGI

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Womens Health Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prenatal Testing
1.2.3 Down Syndrome
1.2.4 HPV
1.2.5 Fertility Test
1.2.6 Pregnancy Test
1.2.7 Other
1.3 Market by Application
1.3.1 Global Womens Health Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Home Care
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Womens Health Diagnostics Market Perspective (2016-2027)
2.2 Womens Health Diagnostics Growth Trends by Regions
2.2.1 Womens Health Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Womens Health Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Womens Health Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Womens Health Diagnostics Industry Dynamic
2.3.1 Womens Health Diagnostics Market Trends
2.3.2 Womens Health Diagnostics Market Drivers
2.3.3 Womens Health Diagnostics Market Challenges
2.3.4 Womens Health Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Womens Health Diagnostics Players by Revenue
3.1.1 Global Top Womens Health Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Womens Health Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Womens Health Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Womens Health Diagnostics Revenue
3.4 Global Womens Health Diagnostics Market Concentration Ratio
3.4.1 Global Womens Health Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Womens Health Diagnostics Revenue in 2020
3.5 Womens Health Diagnostics Key Players Head office and Area Served
3.6 Key Players Womens Health Diagnostics Product Solution and Service
3.7 Date of Enter into Womens Health Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Womens Health Diagnostics Breakdown Data by Type
4.1 Global Womens Health Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Womens Health Diagnostics Forecasted Market Size by Type (2022-2027)

5 Womens Health Diagnostics Breakdown Data by Application
5.1 Global Womens Health Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Womens Health Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Womens Health Diagnostics Market Size (2016-2027)
6.2 North America Womens Health Diagnostics Market Size by Type
6.2.1 North America Womens Health Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Womens Health Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Womens Health Diagnostics Market Size by Type (2016-2027)
6.3 North America Womens Health Diagnostics Market Size by Application
6.3.1 North America Womens Health Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Womens Health Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Womens Health Diagnostics Market Size by Application (2016-2027)
6.4 North America Womens Health Diagnostics Market Size by Country
6.4.1 North America Womens Health Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Womens Health Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Womens Health Diagnostics Market Size (2016-2027)
7.2 Europe Womens Health Diagnostics Market Size by Type
7.2.1 Europe Womens Health Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Womens Health Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Womens Health Diagnostics Market Size by Type (2016-2027)
7.3 Europe Womens Health Diagnostics Market Size by Application
7.3.1 Europe Womens Health Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Womens Health Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Womens Health Diagnostics Market Size by Application (2016-2027)
7.4 Europe Womens Health Diagnostics Market Size by Country
7.4.1 Europe Womens Health Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Womens Health Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Womens Health Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Womens Health Diagnostics Market Size by Type
8.2.1 Asia-Pacific Womens Health Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Womens Health Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Womens Health Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Womens Health Diagnostics Market Size by Application
8.3.1 Asia-Pacific Womens Health Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Womens Health Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Womens Health Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Womens Health Diagnostics Market Size by Region
8.4.1 Asia-Pacific Womens Health Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Womens Health Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Womens Health Diagnostics Market Size (2016-2027)
9.2 Latin America Womens Health Diagnostics Market Size by Type
9.2.1 Latin America Womens Health Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Womens Health Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Womens Health Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Womens Health Diagnostics Market Size by Application
9.3.1 Latin America Womens Health Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Womens Health Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Womens Health Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Womens Health Diagnostics Market Size by Country
9.4.1 Latin America Womens Health Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Womens Health Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Womens Health Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Womens Health Diagnostics Market Size by Type
10.2.1 Middle East & Africa Womens Health Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Womens Health Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Womens Health Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Womens Health Diagnostics Market Size by Application
10.3.1 Middle East & Africa Womens Health Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Womens Health Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Womens Health Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Womens Health Diagnostics Market Size by Country
10.4.1 Middle East & Africa Womens Health Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Womens Health Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Details
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. Womens Health Diagnostics Introduction
11.1.4 Agilent Technologies, Inc. Revenue in Womens Health Diagnostics Business (2016-2021)
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Ariosa Diagnostics, Inc
11.2.1 Ariosa Diagnostics, Inc Company Details
11.2.2 Ariosa Diagnostics, Inc Business Overview
11.2.3 Ariosa Diagnostics, Inc Womens Health Diagnostics Introduction
11.2.4 Ariosa Diagnostics, Inc Revenue in Womens Health Diagnostics Business (2016-2021)
11.2.5 Ariosa Diagnostics, Inc Recent Development
11.3 Bio-Rad Laboratories, Inc
11.3.1 Bio-Rad Laboratories, Inc Company Details
11.3.2 Bio-Rad Laboratories, Inc Business Overview
11.3.3 Bio-Rad Laboratories, Inc Womens Health Diagnostics Introduction
11.3.4 Bio-Rad Laboratories, Inc Revenue in Womens Health Diagnostics Business (2016-2021)
11.3.5 Bio-Rad Laboratories, Inc Recent Development
11.4 Illumina, Inc
11.4.1 Illumina, Inc Company Details
11.4.2 Illumina, Inc Business Overview
11.4.3 Illumina, Inc Womens Health Diagnostics Introduction
11.4.4 Illumina, Inc Revenue in Womens Health Diagnostics Business (2016-2021)
11.4.5 Illumina, Inc Recent Development
11.5 Laboratory Corporation of America Holdings
11.5.1 Laboratory Corporation of America Holdings Company Details
11.5.2 Laboratory Corporation of America Holdings Business Overview
11.5.3 Laboratory Corporation of America Holdings Womens Health Diagnostics Introduction
11.5.4 Laboratory Corporation of America Holdings Revenue in Womens Health Diagnostics Business (2016-2021)
11.5.5 Laboratory Corporation of America Holdings Recent Development
11.6 Natera, Inc
11.6.1 Natera, Inc Company Details
11.6.2 Natera, Inc Business Overview
11.6.3 Natera, Inc Womens Health Diagnostics Introduction
11.6.4 Natera, Inc Revenue in Womens Health Diagnostics Business (2016-2021)
11.6.5 Natera, Inc Recent Development
11.7 PerkinElmer, Inc
11.7.1 PerkinElmer, Inc Company Details
11.7.2 PerkinElmer, Inc Business Overview
11.7.3 PerkinElmer, Inc Womens Health Diagnostics Introduction
11.7.4 PerkinElmer, Inc Revenue in Womens Health Diagnostics Business (2016-2021)
11.7.5 PerkinElmer, Inc Recent Development
11.8 Sequenom, Inc
11.8.1 Sequenom, Inc Company Details
11.8.2 Sequenom, Inc Business Overview
11.8.3 Sequenom, Inc Womens Health Diagnostics Introduction
11.8.4 Sequenom, Inc Revenue in Womens Health Diagnostics Business (2016-2021)
11.8.5 Sequenom, Inc Recent Development
11.9 LifeCodexx
11.9.1 LifeCodexx Company Details
11.9.2 LifeCodexx Business Overview
11.9.3 LifeCodexx Womens Health Diagnostics Introduction
11.9.4 LifeCodexx Revenue in Womens Health Diagnostics Business (2016-2021)
11.9.5 LifeCodexx Recent Development
11.10 Cenata
11.10.1 Cenata Company Details
11.10.2 Cenata Business Overview
11.10.3 Cenata Womens Health Diagnostics Introduction
11.10.4 Cenata Revenue in Womens Health Diagnostics Business (2016-2021)
11.10.5 Cenata Recent Development
11.11 Berrygenomics
11.11.1 Berrygenomics Company Details
11.11.2 Berrygenomics Business Overview
11.11.3 Berrygenomics Womens Health Diagnostics Introduction
11.11.4 Berrygenomics Revenue in Womens Health Diagnostics Business (2016-2021)
11.11.5 Berrygenomics Recent Development
11.12 BGI
11.12.1 BGI Company Details
11.12.2 BGI Business Overview
11.12.3 BGI Womens Health Diagnostics Introduction
11.12.4 BGI Revenue in Womens Health Diagnostics Business (2016-2021)
11.12.5 BGI Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Womens Health Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prenatal Testing
Table 3. Key Players of Down Syndrome
Table 4. Key Players of HPV
Table 5. Key Players of Fertility Test
Table 6. Key Players of Pregnancy Test
Table 7. Key Players of Other
Table 8. Global Womens Health Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Womens Health Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Womens Health Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Womens Health Diagnostics Market Share by Regions (2016-2021)
Table 12. Global Womens Health Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Womens Health Diagnostics Market Share by Regions (2022-2027)
Table 14. Womens Health Diagnostics Market Trends
Table 15. Womens Health Diagnostics Market Drivers
Table 16. Womens Health Diagnostics Market Challenges
Table 17. Womens Health Diagnostics Market Restraints
Table 18. Global Womens Health Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Womens Health Diagnostics Market Share by Players (2016-2021)
Table 20. Global Top Womens Health Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Womens Health Diagnostics as of 2020)
Table 21. Ranking of Global Top Womens Health Diagnostics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Womens Health Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Womens Health Diagnostics Product Solution and Service
Table 25. Date of Enter into Womens Health Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Womens Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Womens Health Diagnostics Revenue Market Share by Type (2016-2021)
Table 29. Global Womens Health Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Womens Health Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Womens Health Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Womens Health Diagnostics Revenue Market Share by Application (2016-2021)
Table 33. Global Womens Health Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Womens Health Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Womens Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Womens Health Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Womens Health Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Womens Health Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Womens Health Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Womens Health Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Womens Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Womens Health Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Womens Health Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Womens Health Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Womens Health Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Womens Health Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Womens Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Womens Health Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Womens Health Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Womens Health Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Womens Health Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Womens Health Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Womens Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Womens Health Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Womens Health Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Womens Health Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Womens Health Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Womens Health Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Womens Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Womens Health Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Womens Health Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Womens Health Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Womens Health Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Womens Health Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Agilent Technologies, Inc. Company Details
Table 66. Agilent Technologies, Inc. Business Overview
Table 67. Agilent Technologies, Inc. Womens Health Diagnostics Product
Table 68. Agilent Technologies, Inc. Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 69. Agilent Technologies, Inc. Recent Development
Table 70. Ariosa Diagnostics, Inc Company Details
Table 71. Ariosa Diagnostics, Inc Business Overview
Table 72. Ariosa Diagnostics, Inc Womens Health Diagnostics Product
Table 73. Ariosa Diagnostics, Inc Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 74. Ariosa Diagnostics, Inc Recent Development
Table 75. Bio-Rad Laboratories, Inc Company Details
Table 76. Bio-Rad Laboratories, Inc Business Overview
Table 77. Bio-Rad Laboratories, Inc Womens Health Diagnostics Product
Table 78. Bio-Rad Laboratories, Inc Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 79. Bio-Rad Laboratories, Inc Recent Development
Table 80. Illumina, Inc Company Details
Table 81. Illumina, Inc Business Overview
Table 82. Illumina, Inc Womens Health Diagnostics Product
Table 83. Illumina, Inc Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 84. Illumina, Inc Recent Development
Table 85. Laboratory Corporation of America Holdings Company Details
Table 86. Laboratory Corporation of America Holdings Business Overview
Table 87. Laboratory Corporation of America Holdings Womens Health Diagnostics Product
Table 88. Laboratory Corporation of America Holdings Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 89. Laboratory Corporation of America Holdings Recent Development
Table 90. Natera, Inc Company Details
Table 91. Natera, Inc Business Overview
Table 92. Natera, Inc Womens Health Diagnostics Product
Table 93. Natera, Inc Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 94. Natera, Inc Recent Development
Table 95. PerkinElmer, Inc Company Details
Table 96. PerkinElmer, Inc Business Overview
Table 97. PerkinElmer, Inc Womens Health Diagnostics Product
Table 98. PerkinElmer, Inc Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 99. PerkinElmer, Inc Recent Development
Table 100. Sequenom, Inc Company Details
Table 101. Sequenom, Inc Business Overview
Table 102. Sequenom, Inc Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 103. Sequenom, Inc Recent Development
Table 104. LifeCodexx Company Details
Table 105. LifeCodexx Business Overview
Table 106. LifeCodexx Womens Health Diagnostics Product
Table 107. LifeCodexx Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 108. LifeCodexx Recent Development
Table 109. Cenata Company Details
Table 110. Cenata Business Overview
Table 111. Cenata Womens Health Diagnostics Product
Table 112. Cenata Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 113. Cenata Recent Development
Table 114. Berrygenomics Company Details
Table 115. Berrygenomics Business Overview
Table 116. Berrygenomics Womens Health Diagnostics Product
Table 117. Berrygenomics Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 118. Berrygenomics Recent Development
Table 119. BGI Company Details
Table 120. BGI Business Overview
Table 121. BGI Womens Health Diagnostics Product
Table 122. BGI Revenue in Womens Health Diagnostics Business (2016-2021) & (US$ Million)
Table 123. BGI Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Womens Health Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Prenatal Testing Features
Figure 3. Down Syndrome Features
Figure 4. HPV Features
Figure 5. Fertility Test Features
Figure 6. Pregnancy Test Features
Figure 7. Other Features
Figure 8. Global Womens Health Diagnostics Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Home Care Case Studies
Figure 11. Womens Health Diagnostics Report Years Considered
Figure 12. Global Womens Health Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Womens Health Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Womens Health Diagnostics Market Share by Regions: 2020 VS 2027
Figure 15. Global Womens Health Diagnostics Market Share by Regions (2022-2027)
Figure 16. Global Womens Health Diagnostics Market Share by Players in 2020
Figure 17. Global Top Womens Health Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Womens Health Diagnostics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Womens Health Diagnostics Revenue in 2020
Figure 19. Global Womens Health Diagnostics Revenue Market Share by Type (2016-2021)
Figure 20. Global Womens Health Diagnostics Revenue Market Share by Type (2022-2027)
Figure 21. North America Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Womens Health Diagnostics Market Share by Type (2016-2027)
Figure 23. North America Womens Health Diagnostics Market Share by Application (2016-2027)
Figure 24. North America Womens Health Diagnostics Market Share by Country (2016-2027)
Figure 25. United States Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Womens Health Diagnostics Market Share by Type (2016-2027)
Figure 29. Europe Womens Health Diagnostics Market Share by Application (2016-2027)
Figure 30. Europe Womens Health Diagnostics Market Share by Country (2016-2027)
Figure 31. Germany Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Womens Health Diagnostics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Womens Health Diagnostics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Womens Health Diagnostics Market Share by Region (2016-2027)
Figure 41. China Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Womens Health Diagnostics Market Share by Type (2016-2027)
Figure 49. Latin America Womens Health Diagnostics Market Share by Application (2016-2027)
Figure 50. Latin America Womens Health Diagnostics Market Share by Country (2016-2027)
Figure 51. Mexico Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Womens Health Diagnostics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Womens Health Diagnostics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Womens Health Diagnostics Market Share by Country (2016-2027)
Figure 57. Turkey Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Womens Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Agilent Technologies, Inc. Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 61. Ariosa Diagnostics, Inc Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 62. Bio-Rad Laboratories, Inc Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 63. Illumina, Inc Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 64. Laboratory Corporation of America Holdings Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 65. Natera, Inc Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 66. PerkinElmer, Inc Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 67. Sequenom, Inc Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 68. LifeCodexx Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 69. Cenata Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 70. Berrygenomics Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 71. BGI Revenue Growth Rate in Womens Health Diagnostics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---